Natural Investments LLC Takes $633,000 Position in The Cigna Group (NYSE:CI)

Natural Investments LLC acquired a new position in shares of The Cigna Group (NYSE:CI - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 2,293 shares of the health services provider's stock, valued at approximately $633,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Cornerstone Advisors LLC grew its holdings in shares of The Cigna Group by 2.6% in the fourth quarter. Cornerstone Advisors LLC now owns 16,000 shares of the health services provider's stock worth $4,418,000 after purchasing an additional 400 shares during the last quarter. Citizens Financial Group Inc. RI lifted its position in The Cigna Group by 3.9% during the fourth quarter. Citizens Financial Group Inc. RI now owns 8,945 shares of the health services provider's stock valued at $2,470,000 after buying an additional 334 shares during the period. Claris Advisors LLC MO lifted its position in The Cigna Group by 5.8% during the fourth quarter. Claris Advisors LLC MO now owns 823 shares of the health services provider's stock valued at $227,000 after buying an additional 45 shares during the period. Morton Community Bank lifted its position in The Cigna Group by 1.7% during the fourth quarter. Morton Community Bank now owns 12,048 shares of the health services provider's stock valued at $3,327,000 after buying an additional 205 shares during the period. Finally, Independent Advisor Alliance lifted its position in The Cigna Group by 179.3% during the fourth quarter. Independent Advisor Alliance now owns 5,895 shares of the health services provider's stock valued at $1,628,000 after buying an additional 3,784 shares during the period. Hedge funds and other institutional investors own 86.99% of the company's stock.

Insider Buying and Selling at The Cigna Group

In other news, insider Nicole S. Jones sold 4,904 shares of the firm's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $308.12, for a total value of $1,511,020.48. Following the completion of the transaction, the insider now directly owns 29,421 shares in the company, valued at $9,065,198.52. This trade represents a 14.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Noelle K. Eder sold 9,944 shares of the firm's stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $320.00, for a total value of $3,182,080.00. Following the completion of the transaction, the insider now owns 13,406 shares of the company's stock, valued at approximately $4,289,920. The trade was a 42.59 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 41,375 shares of company stock worth $12,866,600. 0.60% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the company. Barclays lowered their price objective on The Cigna Group from $420.00 to $339.00 and set an "overweight" rating for the company in a research report on Friday, January 31st. Raymond James reissued a "strong-buy" rating and set a $360.00 price objective (down previously from $415.00) on shares of The Cigna Group in a research report on Friday, January 31st. Wells Fargo & Company lowered their price objective on The Cigna Group from $370.00 to $341.00 and set an "equal weight" rating for the company in a research report on Tuesday, February 4th. StockNews.com raised The Cigna Group from a "hold" rating to a "buy" rating in a research report on Wednesday, February 19th. Finally, Cantor Fitzgerald lowered their price target on The Cigna Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research report on Friday, January 31st. Two equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Buy" and an average target price of $372.31.

Remove Ads

The Cigna Group Trading Down 2.9 %

Shares of NYSE CI opened at $317.24 on Wednesday. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The stock has a market capitalization of $86.82 billion, a P/E ratio of 25.92, a price-to-earnings-growth ratio of 0.98 and a beta of 0.53. The Cigna Group has a 1-year low of $262.03 and a 1-year high of $370.83. The business has a fifty day moving average price of $294.70 and a 200 day moving average price of $317.14.

The Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing analysts' consensus estimates of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same period in the previous year, the firm earned $6.79 earnings per share. Equities research analysts expect that The Cigna Group will post 29.77 EPS for the current fiscal year.

The Cigna Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th will be paid a $1.51 dividend. The ex-dividend date is Wednesday, March 5th. This is a boost from The Cigna Group's previous quarterly dividend of $1.40. This represents a $6.04 dividend on an annualized basis and a yield of 1.90%. The Cigna Group's dividend payout ratio (DPR) is 49.35%.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.